Browsing by Subject "Multiple myeloma"

Now showing items 1-3 of 3

    • Article  

      Levels of absolute survival benefit for systemic therapies of advanced cancer: A call for standards 

      Ioannidis, J. P. A.; Pavlidis, Nicholas (2003)
      Research on systemic interventions in patients with advanced stage malignancies should be systematised with an emphasis on the absolute gain in survival for the median patient. Such information is most meaningful with ...
    • Article  

      Serum anion gap in multiple myeloma patients 

      Elisaf, Moses S.; Siamopoulos, K. C.; Bourantas, C. L.; Papagalanis, N.; Pavlidis, Nicholas (1992)
      The aim of this study was, first, to reconfirm the low serum anion gap (SAG) in multiple myeloma patients and, second, to propose the possible pathophysiologic mechanisms involved. We studied 20 patients with IgG multiple ...
    • Article  

      Serum‐soluble interleukin‐2 receptors in B‐cell lymphoproliferative malignancies 

      Pavlidis, Nicholas; Manoussakis, M. N.; Germanidis, Georgios S.; Moutsopoulos, H. M. (1992)
      The levels of soluble interleukin‐2 receptors (sIL‐2R) were determined in the serum of 53 patients with B‐cell lymphoproliferative malignancies, including 31 patients with non‐Hodgkin lymphomas (NHL), 16 with chronic ...